Tumor accumulation of poly(ethylene glycol) with different molecular weights after intravenous injection

Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents

Volumn 4, Issue 1, 1997, Pages 23-31

  Murakami, Yoshiyuki ^a   Tabata, Yasuhiko ^a   Ikada, Yoshito ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Body distribution; Molecular weight; Poly(ethylene glycol); Tumor accumulation; Tumor size

Indexed keywords

IODINE 125; MACROGOL; POLYMER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACK; BLOOD VESSEL PERMEABILITY; CANCER GRAFT; CANCER SIZE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG TISSUE LEVEL; FEMALE; FIBROSARCOMA; FOOT PAD; INTRAVENOUS DRUG ADMINISTRATION; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS TISSUE TUMOR;

EID: 0030944064     PISSN: 10717544     EISSN: None     Source Type: Journal    
DOI: 10.3109/10717549709033184     Document Type: Article

References (26)

1. Ashihara, Y., Kono, T., Yamazaki, S., and Inada, Y. (1978) Modification of E. coli L-asparaginase with polyethylene glycol: Disappearance of binding ability to anti-asparaginase serum. Biochem. Biophys. Res. Commun. 83, 385-391.
2. Barrowcliffe, M. P., Zanelli, G. D., Ellison, D., and Jones, J. G. (1990) Clearance of charged and uncharged dextran from normal and injured lungs. J. Appl. Physiol. 68, 341-347.
3. 2-macroglobulin. Ann. Biochem. 131, 25-33.
4. Bendich, A., Abuchowski, A., and Davis, F. F. (1982) Immunological effects of native and polyethylene glycol-modified asparaginases from Vibrio succinogenes and Escherichia coli in normal and tumor-bearing mice. Clin. Exp. Immunol. 48, 273-278.
5. Dvorak, H. F., Nagy, J. A., Dvorak, J. T., and Dvorak, A. M. (1988) Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am. J. Pathol. 133, 95-109.
6. Gabizin, A., and Papahadjopoulos, D. (1988) Liposome formations with prolonged circulation time in blood and enhanced uptake by tumors. Proc. Natl. Acad. Sci. USA 85, 6949-6953.
7. 125I-labeled human growth hormone of high specific radioactivity. Biochem. J. 89, 114-123.
8. Hashida, M., Atsumi, R., Nishida, K., Nakane, S., Takakura, Y., and Sezaki, H. (1990) Biliary excretion of mitomycin C dextran conjugates in relation to physicochemical characteristics of carrier dextran. J. Pharmacobiodyn. 13, 441-447.
9. Hershfield, M. S., Buckley, R. H., Greenburg, M. L., Melton, A. L., Schiff, R., Hatem, C., Kurtzberg, J., Marken, M. L., Kobayashi, R. H., Kobayashi, A. L., and Abuchowski, A. N. (1987) Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase. N. Engl. J. Med. 316, 589-596.
10. Heuser, L. S., and Miller, F. N. (1986) Differential macromolecular leakage from the vasculature of tumors. Cancer 57, 461-164.
11. Jain, R. H. (1987) Transport of molecules in the tumor interstitium: A review. Cancer Res. 47, 3039-3051.
12. Kaneo, Y., Tanaka, T., Fujihara, Y., Mori, H., and Iguchi, S. (1988) Delivery of glutathione, as a dextran conjugate, into the liver. Int. J. Pharm. 44, 265-267.
13. Liu, D., Mori, A., and Huang, L. (1992) Role of liposome size and RES blockage in controlling biodistribution and tumor uptake of GM1-containing liposomes. Biochim. Biophys. Acta 1104, 95-101.
14. Maeda, H., and Matsumura, Y. (1989) Tumoritropic and lymphotropic principles of macromolecular drugs. Crit. Rev. Ther. Drug. Carrier Syst. 6, 193-210.
15. Melton, R. G., Wiblin, C. N., Foster, R. L., and Sherwood, R. F. (1987) Covalent linkage of carboxypeptidase G2 to soluble dextran - 11: In vivo distribution and fate of conjugate. Biochem. Pharmacol. 36, 105-112.
16. Przybyski, M., Fell, E., and Ringsdorf, H. (1978) Syntheses and characterization of polymeric derivatives of the antitumor agent. Makromol. Chem. 179, 1733-1791.
17. Seymour, L. W. (1992) Passive tumor targeting of soluble macromolecules and drug conjugates. Ther. Drug. Carrier Syst. 9, 135-187.
18. Sung, C., Youle, R. J., and Dedrick, R. L. (1990) Pharmacokinetic analysis of immunotoxin uptake in solid tumors: Role of plasma kinetics, capillary permeability, and binding. Cancer Res. 50, 7382-7392.
19. Takakura, Y., Atumi, R., Hashida, M., and Sezaki, H. (1990) Disposition characteristics of macromolecules in tumor-bearing mice. Pharm. Res. 7, 339-346.
20. Takakura, Y., Takagi, A., Hashida, M., and Sezaki, H. (1987) Disposition and tumor localization of mitomycin C-dextran conjugates in mice. Pharm. Res. 4, 223-230.
21. Uchiyama, K., Nagayasu, A., Yamagiwa, Y., Nishida, T., Harashima, H., and Kiwada, H. (1995) Effect of the size and fluidity of liposomes on their accumulation in tumors: A presumption of their interaction with tumors. Int. J. Pharm. 121, 195-203.
22. Yamaoka, T., Kuroda, M., Tabata, Y., and Ikada, Y. (1995) Body distribution of dextran derivatives with electric charges after intravenous administration. Int. J. Pharm. 113, 149-157.
23. Yamaoka, T., Tabata, Y., and Ikada, Y. (1993) Body distribution profile of polysaccharides after intravenous administration. Drug Deliv. 1, 75-82.
24. Yamaoka, T., Tabata, Y., and Ikada, Y. (1994) Distribution and tissue uptake of polyethylene glycol with different molecular weights after intravenous administration to mice. J. Pharm. Sci. 83, 601-606.
25. Yamaoka, T., Tabata, Y., and Ikada, Y. (1995) Comparison of body distribution of poly(vinyl alchol) with other water-soluble polymers after intravenous administration. J. Pharm. Pharmacol. 47, 470-486.
26. Yoshimoto, T., Nishimura, H., Saito, Y., Sakurai, K., Kamisaki, Y., Wada, H., Sako, M., Tsujino, G., and Inada, Y. (1986) Characterization of polyethylene glycol-modified L-asparaginase from Escherichia coli and its application to therapy of leukemia. Jpn. J. Cancer Res. (Gann ) 77, 1264-1270.